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Abstract
Respiratory exposure to either multiwalled carbon nanotubes (MWCNT) or asbestos results in 
fibrosis; however, the mechanisms to reach this endpoint may be different. A previous study by 
our group identified pulmonary effects and significantly altered mRNA signaling pathways 
following exposure to 1, 10, 40, and 80 μg MWCNT and 120 μg crocidolite asbestos on mouse 
lungs over time at 1-month, 6-months, and 1-year postexposure following pulmonary aspiration. 
As a continuation to the above study, this current study took an in depth look at the signaling 
pathways involved in fibrosis development at a single time point, 1 year, and exposure, 40 mg 
MWCNT, which was the lowest exposure at which fibrosis was pathologically evident. The 120 μg 
asbestos exposure was included to compare MWCNT-induced fibrosis with asbestos-induced 
fibrosis. A previously validated computational model was used to identify mRNAs with expression 
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profiles matching the fibrosis pathology patterns from exposed mouse lungs. mRNAs that matched 
the pathology patterns were then input into Ingenuity Pathway Analysis to determine potential 
signaling pathways and physiological disease functions inherent to MWCNT and asbestos 
exposure. Both MWCNT and asbestos exposure induced changes in mouse lungs regarding gene 
expression, cell proliferation, and survival, while MWCNT uniquely induced alterations in 
pathways involved in oxidative phosphorylation, mitochondrial dysfunction, and transcription. 
Asbestos exposure produced unique alterations in pathways involved in sustained inflammation. 
Although typically considered similar due to scale and fiber-like appearance, the different 
compositional properties inherent to either MWCNT or asbestos may play a role in their ability to 
induce fibrosis after pulmonary exposure.
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asbestos; multiwalled carbon nanotubes; lung fibrosis; toxicogenomics; pathway analysis; non-
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Introduction
Nanotechnology is the understanding and control of matter at dimensions between 1 and 100 
nanometers that represents a multibillion dollar worldwide industry.1,2 Manipulating matter 
at this scale increases the potential for engineered nanomaterials and nanoscale processes to 
store energy, reinforce materials, sense contaminants, enable life-saving drugs, and shrink 
and accelerate computational devices in incremental and paradigm-shifting ways.2 With the 
wide application of nanomaterials comes the possibility of nanoparticle exposure to workers 
and potential wide-spread exposure due to release of nanoparticles from consumer products, 
particularly during mechanical operations, such as dry and wet cutting of materials, which 
have been shown to release particles of different sizes.3 While nanotechnology focuses on 
the creation and advancement of novel nanotechnology products, nanotoxicology must 
closely follow to assess toxicological risk assessment of nanomaterial design.1,4
Multiwalled carbon nanotubes (MWCNT), multiple concentric rolled up sheets of 
hexagonally-ordered carbon atoms, are appealing for industrial and medical purposes due to 
their unique electrical, thermal, and vibrational properties.5,6 The high aspect ratio and 
surface characteristics of MWCNT contribute to their technological appeal but may also 
contribute to their bioactivity upon exposure during product synthesis and disposal.7,8
MWCNT exposure induces inflammation as early as 1 day postexposure, and fibrosis has 
been noted following MWCNT exposure as early as 1 month postexposure and up to 1 year.
9,10,11,12,13,14
 Gene expression in mouse lungs following MWCNT exposure has also been 
correlated with human lung cancer risk.15 A previous study by our group (Snyder-Talkington 
et al., 2016), exposed mice by aspiration to 1, 10, 40, or 80 μg MWCNT or 120 μg 
crocidolite asbestos and noted increased bronchioalveolar lavage fluid lactate dehydrogenase 
(LDA) activity and polymorphonuclear (PMN) lymphocyte infiltration at 1-month, 6-
months, and 1-year postexposure compared with mice who were exposed to dispersion 
media (DM) control. Elevated LDA activity and PMN infiltration rose with increasing 
MWCNT dose and were also significantly higher than control following exposure to 
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asbestos, suggesting that both MWCNT and asbestos induce lung inflammation up to 1-year 
postexposure.14 PMN infiltration was higher in mouse lungs exposed to 80 μg at 1-year 
postexposure than in lungs exposed to 120 μg asbestos.14 Fibrosis scores of pathologically 
evident fibrosis were also elevated with increasing doses of MWCNT up to 1-year 
postexposure, with the 40 μg exposure of MWCNT being the lowest amount at which 
fibrosis was significantly pathologically evident.14 Analysis of gene expression in mouse 
lungs exposed to 1, 10, 40, or 80 μg MWCNT or 120 μg crocidolite asbestos showed that 
differential gene expression in mouse lungs exposed to MWCNT tended to favor pathways 
involved in protein ubiquitination, cell proliferation and survival, and immune response, 
particularly immune responses mediated by T cells.14
The previous study by Snyder-Talkington et al (2016) showed that asbestos-induced fibrosis 
was associated with high levels of persistent inflammation, while this disease progression 
did not appear to correlate with MWCNT-induced fibrogenic responses. While Snyder-
Talkington et al. (2016) focused on potential mechanisms underlying fibrosis development 
over a period of 1 year following exposure to either MWCNT or asbestos over multiple 
doses, this current study was formed as a continuation of data analysis using the same 
dataset to determine key players involved in biological processes underlying the lung 
fibrosis induced by either MWCNT or asbestos. This current study took a more 
comprehensive look at the biological processes induced at a single dose of MWCNT (40 
μg), the lowest exposure at which fibrosis was pathologically significantly evident at 1-year 
postexposure to MWCNT, and compared these with the biological processes induced by 
asbestos. This study hypothesizes that systematic analysis using a sophisticated 
computational matching of time-series gene expression profiles and MWCNT- or asbestos-
induced fibrosis pathological patterns during 1-year postexposure will identify important 
genes, as well as similar or different signaling pathways, perturbed by these 2 substances. A 
previously validated computational model was used to identify genes with expression 
profiles matching fibrosis pathology patterns from mouse lungs exposed to 40 μg MWCNT 
or 120 μg crocidolite asbestos 1-year postexposure.16 This approach enables the 
identification of genes uniquely relevant to either MWCNT- or asbestos-induced lung 
fibrosis or those matching both MWCNT- and asbestos-induced fibrosis pathological 
patterns. Significantly up- or downregulated genes involved in similar or different pathways 
perturbed by MWCNT or asbestos were pinpointed in this study. These identified genes 
were then analyzed with Ingenuity Pathway Analysis (IPA) to determine differential and 
similar canonical pathways associated with MWCNT- or asbestos-induced lung fibrosis.
Materials and Methods
MWCNT and Crocidolite Asbestos
The MWCNT and asbestos used in this study have been previous characterized. For full 
characterization, please see Snyder-Talkington et al. 2016.14
Animals
All animals were housed in an AAALAC International-accredited, specific-pathogen-free, 
and environmentally controlled facility. All animal studies and procedures were approved by 
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the National Institute for Occupational Safety and Health Animal Care and Use Committee. 
For full characterization of animal husbandry, please see Snyder-Talkington et al. 2016.14
MWCNT and Crocidolite Asbestos Exposure and Lung Collection
All methods for MWCNT and asbestos pulmonary exposure and RNA collection from 
exposed lungs have been previously described.14
Pathology Methods
Lungs were excised from mice exposed to DM; 1, 10, 40, or 80 μg MWCNT; or asbestos at 
1-year postexposure, fixed, and analyzed as previously described.14 This current study only 
concerned lungs from mice exposed to 40 μg MWCNT.
mRNA Microarray Processing
Global mRNA expression profiles were generated with Mouse Gene ST 2.1 plates at the 
University of Michigan Microarray Facility using an Affymetrix Plus kit. cDNA was 
synthesized from 500 ng total RNA, amplified, fragmented, and biotinylated using a 
GeneChip WT PLUS Reagent kit (Affymetrix; Santa Clara, CA) according to 
manufacturer’s instructions. cDNA was then prepared for hybridization with reagents from 
the Affymetrix GeneTitan Hybridization, Wash, and Stain Kit for WT Array Plates. For 
hybridization, 2.76 μg labeled cDNA were hybridized to the Affymetrix Mouse Gene ST 2.1 
Arrays, which were then washed, stained, and scanned using the GeneTitan Multi-Channel 
Instrument according to Affymetrix’s User Guide for Expression Array Plates (P/N 702933 
Rev. 2, 2013). Data were analyzed using the Limma, Oligo, and Affy Bioconductor 
packages implemented in the R statistical environment. The robust multi-array average was 
used to normalize the data and fit log2 transformed expression values. The raw microarray 
data were processed using a robust multi-array average method (Irizarry, et al. 2003), and 
expression values were log2 transformed, with a principal component analysis utilized as the 
final quality control step to visualize mRNA expression values. The analysis was performed 
with the oligo package of Bioconductor in the R statistical environment. The microarray data 
is publically available at NCBI Gene Expression Omnibus with the accession number 
GSE112780 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE112780).
mRNA Microarray Data Analysis
The mRNA microarray consisted of 41,345 probes. Variance was calculated for each probe 
across all samples to remove any probe with variance >0.2. All probes resulted in variance 
<0.2; therefore, no probes were removed due to variance. Unknowns were then removed 
from the data, leaving 25,616 probes. Data analysis was performed with 26,191 probes. 
ANOVA was used to compare each treatment group at each postexposure time point to its 
respective DM control to determine significantly up- and downregulated mRNAs with a p-
value <0.05, false discovery rate of 10%, and fold change (FC) ≥1.5 (Supplemental File 1).
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Identifying genes associated with MWCNT and Crocidolite Asbestos-induced fibrosis 
pathological patterns
The MEGPath system was employed to identify mRNAs with expression transcriptionally 
concordant with fibrotic pathologies in mice exposed to crocidolite asbestos or 40 μg 
MWCNT by aspiration at 1-month, 6-month, or 1-year postexposure as previously 
described.14,16,17 Fibrotic pathology was defined by the analysis of trichrome and Sirius Red 
staining of collagen in mouse lungs at 1 month, 6 months, and 1 year, MWCNT dose 40 μg 
and crocidolite asbestos as previously reported.14 Using constraint-based non-negative 
matrix factorization, underlying biological patterns were identified, where fibrotic pathology 
was used as the constraint.18 Identified patterns were then related back to gene expression 
profiles producing genome-wide coefficients that related each gene to varying pathological 
patterns. Sets of genes with expressions matching the fibrotic pathological patterns were 
identified from the annotated C2 and C5 datasets of the curated Molecular Signatures 
Database (MSigDB).19 Genes may be contained in multiple biological processes and 
pathways. The gene sets were functionally related by annotations and belonged to the same 
biological process, but were not required to be coexpressed.16 This method was used to 
identify genes with expression concordant with time-series fibrosis pathological patterns 
induced by MWCNT dose 40 μg and crocidolite asbestos, genes concordant uniquely with 
MWCNT dose 40 μg, and genes concordant uniquely with crocidolite asbestos.
IPA analysis to identify pathways, diseases and physiological functions
IPA (QIAGEN, Redwood City, CA, www.qiagen.com/ingenuity) was used to determine 
mRNAs associated with canonical pathways and diseases and functions. All associations are 
supported by at least one reference from the literature, from a textbook, or from canonical 
information stored in the Ingenuity Knowledge Base.
Results
In this study, similar and different pathways and biological processes underlying lung 
fibrosis induced by MWCNT or asbestos were identified using mRNA data and 
histopathological quantification of lung fibrosis from mice exposed to 40 μg MWCNT or 
120 μg crocidolite asbestos (Figure 1). Asbestos and MWCNT are often thought to similarly 
result in inflammation and fibrosis following exposure due to their similar fibrous nature; 
however, MWCNT and asbestos have differing lengths and compositions that may contribute 
to different signaling pathways leading to these outcomes following exposure (Figure 2). 
The 40 μg MWCNT treatment was selected as this is an occupationally-relevant exposure to 
MWCNT and is the lowest quantity at which pathologically evident fibrosis was induced.14 
A novel computational model (MEGPath) was used to identify mRNAs that either matched 
the MWCNT 40 μg fibrosis pathology pattern, asbestos pathology pattern, or both the 
MWCNT 40 μg and asbestos pathology patterns over the 1-year postexposure time course. 
These identified genes were then input into IPA (Fall Release 2016) to determine potential 
signaling pathways and physiological disease functions inherent to MWCNT and asbestos. 
A total of 2,462 mRNAs matched the MWCNT 40 μg pathology pattern, 3,669 mRNAs 
matched the asbestos pathology pattern, and 3,551 mRNAs matched both 40 μg and asbestos 
patterns (Supplemental File 1). Among the identified genes involved in similar or different 
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pathways underlying MWCNT and asbestos-induced lung fibrosis, those significantly up- or 
downregulated genes are summarized in Table 1.
Identifying pathways associated with the MWCNT 40 μg or asbestos pathology patterns
The 2,462 genes that were concordant with MWCNT 40 μg pathology pattern and the 3,669 
genes that were concordant with asbestos were input into IPA. A Core Analysis was run on 
each set of mRNAs, followed by a Comparison Analysis to determine signaling pathways in 
which both the MWCNT 40 μg and asbestos genes were involved. A review of the 
Comparison Analysis was completed to determine the top 5 canonical pathways in which 
more MWCNT 40 μg mRNAs were involved than asbestos mRNAs and the top 5 canonical 
pathways in which more asbestos mRNAs were involved than MWCNT 40 μg mRNAs. 
Genes involved in each of the top 5 canonical pathways were then analyzed to determine 
those genes that were both involved in the identified pathways and significantly up- or 
downregulated.
MWCNT 40 μg—The top 5 pathways associated with mRNA expression that was 
concordant with the MWCNT 40 μg pathology pattern versus the asbestos pathology pattern 
were EIF2 signaling, regulation of eIF4 and p70S6K signaling, hereditary breast cancer 
signaling, mitochondrial dysfunction, and oxidative phosphorylation (Figure 3). Of the 
genes involved in these pathways, CHECK2 was significantly downregulated at 1-month 
postexposure; COX7B was significantly upregulated and RPL7 was significantly 
downregulated at 6-months postexposure. EIF3F, RPL5, RPL29, RPL36AL, RPS8, RPS13, 
RPS16, RPS19, PARK7, and SDHB were significantly downregulated at 1-year 
postexposure (Table 1).
Asbestos—The top 5 pathways associated with mRNA expression that was concordant 
with the asbestos pathology pattern versus the MWCNT 40 μg pathology pattern were 
glucocorticoid receptor signaling, NF-κB signaling, Molecular Mechanisms of Cancer, 
production of nitric oxide and reactive oxygen species in macrophages, and B cell receptor 
signaling (Figure 4). Of the genes involved in these pathways, BMPR2 was significantly 
upregulated at 1-month postexposure; CCL3, JUN, KRAS, MAP2K1, NFKBIA, PIK3CD, 
PIK3RA, PIK3R5, PIK3R4, APAF1, LRP1, MAP3K2, SIRPA were significantly 
upregulated at 6-months postexposure; and CCL5, IL1B, CYBA, and CD79B were 
significantly downregulated at 1-year postexposure (Table 1).
Identifying pathways associated with both the MWCNT 40 μg and asbestos patterns
The 3,551 genes that were concordant with MWCNT 40 μg pathology pattern and asbestos 
pathology were inputted into IPA. A Core Analysis was run on the set of mRNAs to 
determine the top 5 canonical pathways associated with both MWCNT 40 μg mRNA 
pathology pattern expression and asbestos mRNA pathology pattern expression.
The top 5 canonical pathways associated with mRNA expression that were concordant with 
both the MWCNT 40 mg and asbestos pathology patterns were Molecular Mechanisms of 
Cancer, Glucocorticoid Receptor Signaling, NF-κB Signaling, G-Protein Coupled Receptor 
Signaling, and Role of NFAT in Cardiac Hypertrophy (Figure 5). Of the genes involved in 
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these pathways, BMPR2 was significantly upregulated and NFKB1, CHEK2, CYCS, TAF2, 
ICAM1, and MYD88 were significant downregulated at 1-month postexposure; APAF1, 
LRP1, PIK3R5, PRKCH, NFKBIA, PIK3CD, KRAS, ARHGEF1, PIK3R4, MAP2K1, 
CCL3, FPR2, and PTGER3 were upregulated and TGFA was downregulated at 6-months 
postexposure; and PTGER3 was upregulated and HDAC10, TRAF5, ARAF, CCL5, CD3G, 
CYCS, and RHOH were downregulated at 1-year postexposure (Table 1).
Discussion
Inflammation and fibrosis are hallmarks of both MWCNT and asbestos lung exposure, 
potentially due to their high aspect ratio and biopersistence.11,20,21 While the endpoint of 
exposure to both MWCNT and asbestos may be similar, the mechanisms to reach this 
endpoint may be different. Previously, Snyder-Talkington et al (2016) showed that asbestos-
induced fibrosis was associated with high levels of persistent inflammation, while this 
disease manifestation did not appear to correlate with MWCNT-induced fibrogenic 
responses. Increasing doses of MWCNT-induced genomic profiles of fibrosis were 
associated with numerous diseases, including lung cancer and canonical pathways involved 
in the immune response.15 Lung carcinogenicity of MWCNT exposure was later confirmed 
in animal studies.22,23 In this study, a systematic approach was used to determine similar and 
differing pathways and biological processes associated with lung fibrosis induced by 
MWCNT and asbestos at a single MWCNT exposure at which lung fibrosis was first 
significantly pathologically evident.
This study utilized a sophisticated computational model (MEGPath) to discover genes 
whose transcriptional activities uniquely matched lung fibrosis pathology patterns of either 
MWCNT or asbestos over the 1-year postexposure time course with three time points: 1 
month, 6 months, and 1 year. These genes revealed different biological processes and 
pathways underlying exposure to these two substances. Genes whose expression profiles 
matched both MWCNT and asbestos pathology patterns were also identified; the canonical 
pathways represented by these genes might be relevant to similar disease mechanisms 
underlying MWCNT- and asbestos-mediated lung fibrosis. The novel computational analysis 
of matching time-course gene expression profiles with pathology patterns using non-
negative matrix factorization identified genes functionally involved in similar and differing 
processes of fibrotic pathogenesis induced by MWCNT and asbestos, offering important 
insight into the toxicity assessment of these two substances.
The major advantages of the time-series method compared with the previous single time-
point analysis are: 1) pathological patterns of lung fibrosis over the 1-year post-exposure 
time course were used as constraints to identify genes that had transcriptional activities 
similar to the pathological patterns. Such computational ability is not possessed by the 
earlier single time-point analysis. 2) The current time-series analysis could also identify 
genes that are more similar to MWCNT-induced fibrotic pathological patterns than asbestos- 
induced ones. The identified genes are considered to be more relevant to MWCNT-induced 
lung fibrosis pathogenesis. Similarly, genes more relevant to asbestos-induced lung fibrosis 
could also be identified by using the time-series method. When both MWCNT and asbestos-
induced fibrotic pathological patterns are used as constraints in the time series method, 
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genes that had transcriptional profiles matching both pathology patterns were identified and 
considered to be relevant to both MWCNT and asbestos-induced fibrotic pathogenesis. Only 
the time-series method has the capacity to identify unique and similar genes and biological 
pathways perturbed by MWCNT and asbestos exposures, whereas the earlier single time-
point analysis does not have all these features. Many of our identified genes were not 
previously reported as relevant to lung fibrosis induced by MWCNT or asbestos in the 
current Ingenuity Knowledge Base. These findings provide evidence that the transcriptional 
activities of the genes identified in this study were associated with MWCNT- or asbestos-
induced fibrosis in mouse lungs.
It is noteworthy that BMPR2 appears in both the asbestos-only analysis and the MWCNT 40 
μg and asbestos analysis at 1 month, similarly for CCL5 at 1 year (Table 1). The MWCNT 
40 μg and asbestos analysis was run with a single constraint that found gene sets which were 
significantly associated with the single combined fibrosis pattern in both MWCNT 40 μg 
exposed mice and the asbestos treated mice. A gene could have associated so strongly with 
asbestos and almost significantly associated with MWCNT that it would be associated with 
asbestos and MWCNT when looking at the constraint which included both pathological 
patterns. The other two columns in Table 1 were found from a separate analysis which ran 
with two constraints, asbestos and MWCNT 40 μg, respectively. This was to find genes that 
were very strongly related to one of the constraints. Details of the computational analysis of 
matching time-course genomic profiles with pathology patterns were provided in our 
previous studies of time-series of MWCNT exposure at 1 day, 28 days, and 56 days 
postexposure.16
The top five signaling pathways uniquely associated with the MWCNT 40 μg pathology 
pattern were most often involved in protein synthesis, DNA replication and repair, cell cycle 
and survival, and metabolic diseases. Significantly up- and downregulated genes within 
these pathways suggest a role for increased oxidative phosphorylation and mitochondrial 
dysfunction and decreased transcriptional ability. The tumor suppressor CHEK2 was 
significantly downregulated at 1-month postexposure to MWCNT 40 μg, suggesting 
potential for increased growth and proliferation following MWCNT exposure. Several 
ribosomal proteins (RPL7, RPL5, RPL29, RPL36AL, RPS8, RPS13, RPS16, and RPS19) 
were found to be downregulated at 1-year postexposure. These proteins belong to the small 
and large subunits of the larger ribosomal subunits, suggesting that protein translation may 
be affected following MWCNT exposure, an effect that has overarching effects on cell 
growth, proliferation, differentiation, and development.24 Disturbances in ribosomal 
biogenesis can result in ribosomal stress and the release of ribosome-free forms of ribosomal 
proteins, which can have numerous extraribosomal functions, such as activation of tumor 
suppressor p53 or oncogenic processes.24 In particular, RPL5 has been shown to activate 
tumor suppressor p53, and this activation may be lost by the loss of RPL5 following 
MWCNT exposure.24 The abundance of alterations in ribosomal proteins following 
MWCNT exposure that is not evident following asbestos exposure may suggest that 
MWCNT have greater effects on ribosomal stress. An interesting finding that correlated with 
our previous study was downregulation of oxidative stress sensor PARK7. PARK7 
downregulation may play a role in loss of oxidative stress protection and also a role for 
mitochondrial dysfunction following MWCNT exposure.14
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The top five signaling pathways uniquely associated with the asbestos pathology pattern 
were more often involved in cellular development, cellular growth and proliferation, gene 
expression, and free radical scavenging. Significantly up- and downregulated genes within 
these pathways suggest increased sustained inflammation over time after asbestos exposure 
with enhanced cellular growth. Asbestos exposure has been linked to diseases such as 
pulmonary fibrosis (asbestosis), pleural effusion and plaques, and malignancies, such as 
bronchogenic carcinoma and mesothelioma.25,26 Inflammation and reactive oxygen species-
induced DNA damage resulting in apoptosis are well-known effects attributed to asbestos 
exposure.25 Genes involved in inflammation (CCL3, CCL5, NFKBIA, and IL1B) and 
apoptosis (APAF1 and LRP1) were significantly up- and downregulated in our study. 
Further, asbestos exposure has been consistently linked to development of asbestos-
associated lung cancer.25 Numerous genes involved in growth (PIK3RA, PIK3R5, PIK3R4, 
SIRPA), proliferation (MAP2K1), and malignancy (JUN, KRAS) were up- and 
downregulated in our study of genes significantly associated with asbestos pathology 
patterns.
The top five signaling pathways associated with both MWCNT 40 μg and asbestos 
pathology patterns were most often involved in cellular development and survival, cellular 
growth and proliferation, gene expression, and posttranslational modification. Significantly 
up- and downregulated genes in pathways associated with both MWCNT and asbestos 
suggest increases in growth and proliferation over time with changes in mitochondrial 
function and transcription. Both MWCNT and asbestos exposure were found to result in 
lung fibrosis over time; however, previous research suggested that this endpoint is reached 
through differing mechanisms.14 In this study, several significantly up- and downregulated 
genes were identified by IPA to be involved in the overall process of fibrosis. Following 
asbestos exposure, the upregulated genes BMPR2, JUN, KRAS, and NFKIA were found to 
be involved in the fibrosis process. In signaling pathways that were representative of both 
MWCNT and asbestos pathology, the upregulated genes NFKBIA and KRAS and the 
downregulated genes NFKB1, ICAM1, MYD88, and TGFA were shown to be involved in 
the fibrosis process. No specific fibrosis-related genes were found to be up- or 
downregulated in the top signaling pathways representative of only MWCNT exposure. 
These findings may further validate varying fibrotic patterns of MWCNT versus asbestos 
exposure.
The computational analysis used in this study discovered genes with time-series expression 
profiles matching pathological patterns induced by MWNCT and/or asbestos over the course 
of three time points: 1-month, 6-months, and 1-year postexposure. The identified 
significantly up- and downregulated genes associated with MWCNT- and asbestos-induced 
pathology patterns were significantly represented in different signaling pathways. Although 
MWCNT and asbestos may result in similar outcomes, the pathways to these endpoints may 
be different due to different sizes and compositions of the different particles. This study, a 
follow-up to the previous study by Snyder-Talkington et al. (2016), identified significant 
similar and differential signaling pathways associated with MWCNT and asbestos exposure 
at increasing doses over time. This study presented results on one MWCNT exposure, 40 μg, 
over time to identify signaling pathways associated with the lowest exposure to MWCNT at 
which significant pathologically evident fibrosis was identified (results on the comparison of 
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MWCNT 80 μg and asbestos are included in Supplementary File 2). In particular, an 
alteration in ribosomal proteins was identified following MWCNT exposure that was not 
identified when asbestos exposure was analyzed. This finding suggests that MWCNT may 
induce ribosomal stress, in addition to mitochondrial stress identified previously, which can 
have long-term detrimental effects on the lung.14 In contrast, numerous genes involved in 
inflammation, growth, proliferation, apoptosis, and malignancy were perturbed and uniquely 
associated with asbestos pathology patterns. It is noteworthy that among the genes matching 
both MWCNT- and asbestos-induced fibrotic pathology patterns, NFKBIA and NFKB1 had 
significant differential expression in mouse lungs, which is consistent with the previous 
prediction of NF-κB regulation of MWCNT-induced gene expression changes in qRT-PCR 
assays of a panel of lung cancer signaling hallmarks and biomarkers in human small airway 
epithelial cells (SAEC).27 Moreover, our previous systematic analysis of MWCNT-induced 
cellular signaling and gene expression in SAEC showed that MWCNT exposure induced a 
concordant increase of both mRNAs and proteins of CCL2 and VEGFA, two prognostic 
biomarkers of lung inflammation, fibrosis, and carcinogenesis.27 Although adenocarcinoma 
formation was not identified in this current study, there were several changes in genes 
involved in oncogenic processes in this study which may set the stage for tumor 
development in the long term. Gene expression signatures in mouse lungs following 
MWCNT exposure were previously identified to predict human lung cancer risk.15 MWCNT 
was later confirmed as a promoter of lung adenocarcinoma formation as well as a tumor 
initiator.22,23,28
Both MWCNT and asbestos exposure produces changes in mouse lungs regarding gene 
expression, cell proliferation, and survival. MWCNT uniquely produce alterations in 
pathways involved in oxidative phosphorylation, mitochondrial dysfunction, and 
transcription, while asbestos exposure produces unique alterations in pathways involved in 
sustained inflammation. These results suggest that asbestos exposure may lead to fibrosis 
through a continuous inflammatory process, while MWCNT exposure leads to fibrosis 
through different means. Although similar in scale, the differential compositional properties 
of MWCNT versus asbestos may play into their fibrotic potential. Limitations of this study 
include the use of whole lungs for genomic analysis in place of subpopulations of specific 
cell types. The validation of the signaling pathways and overall cellular changes identified in 
this study are an ongoing endeavor.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Study overview.
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Figure 2. 
Left lung trichrome and Sirius red pathology staining at 1 year. Lung sections were 
evaluated by visualization of collagen at 4× magnification. (A) DM (negative control) 
trichrome staining; (B) mild fibrosis with focal emphysema, 40 μg MWCNT, trichrome 
staining; (C) mild fibrosis with focal emphysema, 80 μg MWCNT, trichrome staining; (D) 
mild fibrosis, 120 μg asbestos, Sirius red staining.
Dymacek et al. Page 14
Int J Toxicol. Author manuscript; available in PMC 2019 August 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. 
Top 5 IPA pathways associated with mRNA expression concordant with the MWCNT 40 μg 
pathology pattern versus the asbestos pathology pattern.
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Figure 4. 
Top 5 IPA pathways associated with mRNA expression concordant with the asbestos 
pathology pattern versus the MWCNT 40 μg pathology pattern.
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Figure 5. 
Top 5 canonical pathways associated with mRNA expression concordant with both the 
MWCNT 40 μg and asbestos pathology patterns.
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Table 1:
Significantly up- and downregulated genes at 1-month, 6-month, and 1-year postexposure to MWCNT 40 μg 
and asbestos. Genes that were uniquely associated with pathology of MWCNT 40 μg, but not asbestos, are 
listed in the column “MWCNT 40 μg”; genes that were uniquely associated with pathology of asbestos, but 
not MWCNT 40 μg, are listed in column asbestos; genes that are associated with both MWCNT 40 μg and 
asbestos pathology are listed in column “MWCNT 40 μg AND asbestos”.
MWCNT 40 μg Asbestos MWCNT 40 μg AND asbestos
Upregulated Downregulated Upregulated Downregulated Upregulated Downregulated
1 month CHEK2 BMPR2 BMPR2 NFKB1, CHEK2, 
CYCS, TAF2, 
ICAM1, MYD88
6 
months
COX7B RPL7 CCL3, JUN, 
KRAS, 
MAP2K1, 
NFKBIA, 
PIK3CD, 
PIK3RA, 
PIK3R5, 
PIK3R4, APAF1, 
LRP1, MAP3K2, 
SIRPA
APAF1, LRP1, 
PIK3R5, PRKCH, 
NFKBIA, 
PIK3CD, KRAS, 
ARHGEF1, 
PIK3R4, 
MAP2K1, CCL3, 
FPR2, PTGER3
TGFA
1-year EIF3F, RPL5, 
RPL29, RPL36AL, 
RPS8, RPS13, 
RPS16, RPS19, 
PARK7, SDHB
CCL5, IL1B, 
CYBA, CD79B
PTGER3 HDAC10, TRAF5, 
ARAF, CCL5, CD3G, 
CYCS, RHOH
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